BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Wednesday, March 11, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
June 16, 2020
View Archived Issues
Identification of oral hydroxpyridinone iron chelator for the treatment of iron overload
Read More
"Gastruloids" enable study of embryonic development
Read More
ApoE4's role in Alzheimer's blood vessels
Read More
Neurocrine Biosciences reports positive results with crinecerfont in congenital adrenal hyperplasia
Read More
SARS-CoV-2 neutralizing MAb identified from memory B cells of an individual infected with SARS-CoV
Read More
RemeGen studies RC-88 in phase I for advanced malignant solid tumors
Read More
MT-7117 enters phase III for erythropoietic protoporphyria and X-linked protoporphyria
Read More
[18F]EKZ-001 PET radioligand targeting brain HDAC6: cGMP production and target occupancy in NHPs
Read More
Antisense PNAs targeting lpxB gene inhibit A. baumannii growth and synergize with colistin
Read More
Bayer initiates phase III FINEARTS-HF study of finerenone in heart failure
Read More
First patient dosed in phase II study of ATYR-1923 in COVID-19 with severe respiratory complications
Read More
PDS Biotech and NCI initiate phase II study of PDS-0101
Read More
Pivotal trial of darinaparsin in peripheral T-cell lymphoma meets primary endpoint
Read More
Cue Biopharma advances phase I study of CUE-101 in head and neck cancer
Read More
RICTOR as a new therapeutic target for lung cancer brain metastases
Read More
Phase II data presented from ORIENT-2 study of sintilimab advanced refractory ESCC
Read More
New SHP-2 inhibitors identified at Tuojie Biotech
Read More
Shanghai Pharmaceuticals Holding patents MAPK11 and 14 inhibitors
Read More
New Mnk1 and Mnk2 inhibitors discovered at Shanghai De Novo Pharmatech
Read More
New dual CDK-HDAC inhibitors synthesized at Hangzhou Innogate Pharma
Read More
Janssen discovers compounds active against respiratory syncytial virus
Read More
The Treg-selective long-acting IL-2 variant CUG-252 reduces inflammation in vitro and in vivo
Read More
Favorable safety, pharmacodynamic activity seen with FT-4202 in phase I study
Read More
FDA grants accelerated approval to Zepzelca for metastatic SCLC
Read More
Janssen plans phase II development of JNJ-40411813 for epilepsy
Read More
Phase IIb study of lanifibranor in NASH meets primary and key secondary endpoints
Read More
FDA approves Lyumjev for type 1 and type 2 diabetes
Read More
